http://rdf.ncbi.nlm.nih.gov/pubchem/patent/ES-2514093-B1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1b74695f4c6259a8598b722c1ef6eefa http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7da5c8e8c3e8261efe7e698c7198681b |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4196 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-422 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4245 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-404 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D209-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-404 |
| filingDate | 2013-03-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2015-08-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3cad8171ee96423ff8bc85e516d8209f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8e7f78b1c6ea4c7c78470b1821a51faf http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cf17de60b84e8e03e4750f465d1683ff http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_414ebbff66e29366b13660ff91caad8a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2c242f20ae543ff5b1b463d222b6c436 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_213f23f769eb26d97b31510e652225c5 |
| publicationDate | 2015-08-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | ES-2514093-B1 |
| titleOfInvention | NEELOGENIC COMPOUNDS BASED ON MELATONIN AND ITS USE IN THE TREATMENT OF NERVOUS SYSTEM DISEASES |
| abstract | Neurogenic compounds based on melatonin and their use in the treatment of diseases of the nervous system. # The present invention, which is included in the field of research and pharmaceutical industry, refers to new chemical entities derived from melatonin with neurogenic properties, modulators of melatonin and / or serotonin receptors, antioxidants and / or cholinergic. It also refers to the procedures for the preparation of these new compounds, the pharmaceutical compositions containing them and their use for the manufacture of a medicament for the treatment of diseases of the nervous system related to neuronal degeneration, depression, psychiatric and cognitive disorders, trauma or cell injury, or other related neurological disorder, treatment of daytime fatigue, sleep disorders, loss of mental efficacy, weakness and irritability and symptoms related to hourly decompensation (jet-lag effect or transoceanic syndrome). |
| priorityDate | 2013-03-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 328.